Protein arginine methyltransferase 5 (PRMT5), a Type II arginine methyltransferase, which has been reported to be involved in the regulation of multiple tumorigenesis pathways, usually can only be stained by immunohistostaining on tumor biopsy (35, 36). This evidence concerns the gene PRMT5 and neoplasm.